China approves 17 anti-cancer drugs for medical insurance coverage Medical Dialogues Bureau10 Oct 2018 4:49 AM GMTSHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said, part of its efforts to...
NPPA fixes maximum retail prices of 92 drugs, details Ruby16 Aug 2018 12:22 PM GMTNew Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
Merck KGaA's lung cancer drugs show promise in early-stage trials Ruby17 May 2018 4:15 AM GMTFRANKFURT: Germany’s Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially ...
Lupin's JV completes global trials for rheumatoid arthritis biosimilar Ruby8 Feb 2018 5:30 AM GMTPUNE: Drug major Lupin said its joint venture with Japanese firm Yoshindo, YL Biologics, has completed global phase III trials of its Etanercept...
Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa Ruby20 Nov 2017 4:48 AM GMTMumbai: Leading private sector hospital chain Narayana Hrudayalaya has chalked out a Rs 500 crore expansion plan, which will see it entering...
Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US supriya15 April 2017 4:10 AM GMTRoyal Philips, a global leader in health technology, announced it has received regulatory clearance (via De Novo classification) from the U.S. Food...
Investments set India as hot healthcare destination: PWC Report supriya26 March 2017 5:38 AM GMTMumbai : Private equity and venture capital funding in healthcare over the past five years along with a slew of investments from global players has...
Mylan Launches Generic Aromasin® Tablets supriya17 March 2017 6:22 AM GMT England : Mylan N.V. announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference listed drug, Pfizer's Aromasin®...
Dr Reddy's Lab acquires Kolkata-based NBFC supriya6 March 2017 6:17 AM GMTNew Delhi : Dr Reddy's Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-banking...
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion supriya14 Feb 2017 7:08 AM GMTBotox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by...
Daiichi Sankyo closes RnD Division in India savita12 Jan 2017 7:41 AM GMTMUMBAI: Daiichi Sankyo India Pharma Pvt. Ltd. (DSIN), an organization working in the field of innovative pharmaceutical Research & Development...
USFDA Accepts BLA for Mylan and Biocon's Proposed Biosimilar Trastuzumab supriya12 Jan 2017 5:52 AM GMTBengaluru : Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration has accepted Mylan's biologics license application (BLA)...
